Read + Share
Amedeo Smart
Independent Medical Education
Shanmuganathan N, Branford S. Multiplex technologies for the assessment of minimal residual disease and low-level mutation detection in leukaemia: mass spectrometry versus next-generation sequencing. Br J Haematol 2022;196:19-30.PMID: 34124782
Email
LinkedIn
Facebook
Twitter
Privacy Policy